RankingsPricing
  1. JP-listed companies
  2. NANO MRNA Co.,Ltd.
  3. Financials
  4. Income before tax

NANO MRNA Co.,Ltd.【JP:4571】

Market cap
¥10.3B
P/E ratio
-9.9x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndIncome before tax (Million JPY)YoY (%)
Mar 31, 2025-688-8.31%
Mar 31, 2024-750-32.11%
Mar 31, 2023-1,105-42.63%
Mar 31, 2022-1,925+50.56%
Mar 31, 2021-1,279+11.74%
Mar 31, 2020-1,144-35.51%
Mar 31, 2019-1,774-66.55%
Mar 31, 2018-5,304+102.53%
Mar 31, 2017-2,619+9.99%
Mar 31, 2016-2,381+1290.28%
Mar 31, 2015-171-84.36%
Mar 31, 2014-1,095+153.39%
Mar 31, 2013-432+18.00%
Mar 31, 2012-366

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)